Powered by

-Ultragenyx to Present at Jefferies Gene Therapy Editing Summit

Oct 03, 2019 - ENP Newswire
Event Announcements

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases, today announced that Emil Kakkis, the company's Chief Executive Officer and President will present at the Jefferies Gene Therapy/Editing Summit on Tuesday, October 8, 2019 at 9:45 AM ET in New York, NY.

The live and archived webcast of the company presentations will be accessible from the company's website at http:/...